Vigene Biosciences, A Charles River Company Overview
Summary
Vigene Biosciences, A Charles River Company is a private company that has been in the industry for 13 years. The company currently specializes in the Biotechnology, Biotechnology areas. The position of the Chairman & CEO is occupied by Zairen Sun. Its headquarters is located at Rockville, Maryland, USA. The number of employees ranges from 100 to 250. The annual revenue of Vigene Biosciences, A Charles River Company varies between 25M and 100M. Total funding of the company - $11.5M. To connect with Vigene Biosciences, A Charles River Company employee register on SignalHire.
Industries
Biotechnology
Headquarters Location
Employees Size
100-200 employees
Specialties
miRNA cloning, Adenovirus production, Gene delivery, custom service, adenoviral vector, Lentivirus, AAV, cGMP, Biosensors, Zika, lentivirus, custom cloning, AAV Biosensors, AAV production, cGMP AAV manufacturing, cGMP lentivirus production, Plasmid production, cGMP plasmid production, lentivirus production, AAV reference materials, Fill & Finish, Cell & Virus Banking, Retrovirus Production, cGMP Retrovirus Production, cGMP QC Services, Viral Vector Production
SIC Code
2836
DMA Code
Washington Metropolitan Area
Founded
2012
Estimated Annual Revenue
$25M - 100M
Operating Status
Acquired
Contact Vigene Biosciences, A Charles River Company
Organization Website
Social Links
Phone Number
1-301-251-6638
Competitors
Founded | Type | Employees | Revenue | Funding | |
---|---|---|---|---|---|
2008 | Privately Held | 25 - 100 | 14.2M | $89.1M | |
2011 | Privately Held | 100 - 250 | 225.1M | $220.1M | |
1993 | Public Company | 1.0K - 5.0K | 50.2M | $526.4M | |
2011 | Public Company | 500 - 1.0K | 164M | $933M | |
2003 | Privately Held | 25 - 100 | 5.3M | $10.3M | |
2014 | Public Company | 100 - 250 | 132.2M | $267.1M | |
1996 | Public Company | 25 - 100 | 34.7M | $318.6M | |
2016 | Privately Held | 500 - 1.0K | 250M | $0 | |
2012 | - | 100-200 | - | $- | |
2019 | - | 10-50 | - | $- | |
2008 | - | 200-500 | - | $- | |
1967 | - | 200-500 | - | $- | |
1987 | - | 10000+ | - | $- |